|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 18, 14987-14995, May 4, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Thyroid hormone receptors (TRs) bind as
homodimers or heterodimers with retinoid X receptors (RXRs) to DNA
elements with diverse orientations of AGGTCA half-sites. We
performed a comprehensive x-ray crystal structure-guided mutation
analysis of the TR ligand binding domain (TR LBD) surface to map
the functional interface for TR homodimers and heterodimers with RXR in
the absence and/or in the presence of DNA. We also identified the
molecular contacts in TR LBDs crystallized as dimers. The results show
that crystal dimer contacts differ from those found in the functional
studies. We found that identical TR LBD residues found in helices 10 and 11 are involved in TR homodimerization and heterodimerization with
RXR. Moreover, the same TR LBD surface is operative for dimerization with direct repeats spaced by 4 base pairs (DR-4) and with the inverted palindrome spaced by 6 base pairs (F2), but not
with TREpal (unspaced palindrome), where homodimers appear to be simply two monomers binding independently to DNA. We also demonstrate that
interactions between the TR and RXR DNA binding domains stabilize TR-RXR heterodimers on DR-4. The dimer interface can be
functional in the cell, because disruption of key residues impairs
transcriptional activity of TRs mediated through association with RXR
LBD linked to GAL4 DNA-binding domain.
Definition of the Surface in the Thyroid Hormone
Receptor Ligand Binding Domain for Association as Homodimers and
Heterodimers with Retinoid X Receptor*
§¶,
,
,
,
,

Metabolic Research Unit Department of
Medicine and the ** Department of Biochemistry and Biophysics,
University of California, San Francisco, California 94143 and the
§ Department of Pharmaceutical Sciences, University of
Brasilia, DF 70910-900, Brazil
*
This work was supported by National Institutes of Health
Grants DK41842 (to R. J. K.) and DK09516 (to J. D. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipient of a postdoctoral fellowship from the National
Institutes of Health.

Proprietary interests in and serves as a consultant and Deputy
Director to Karo Bio AB, which has commercial interests in this area of research.
This article has been cited by other articles:
![]() |
M. T. Sonoda, L. Martinez, P. Webb, M. S. Skaf, and I. Polikarpov Ligand Dissociation from Estrogen Receptor Is Mediated by Receptor Dimerization: Evidence from Molecular Dynamics Simulations Mol. Endocrinol., July 1, 2008; 22(7): 1565 - 1578. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chaudhuri Nuclear Receptors and Female Reproduction: A Tale of 3 Scientists, Jensen, Gustafsson, and O'Malley Reproductive Sciences, February 1, 2008; 15(2): 110 - 120. [Abstract] [PDF] |
||||
![]() |
E. H. Jeninga, O. van Beekum, A. D. J. van Dijk, N. Hamers, B. I. Hendriks-Stegeman, A. M. J. J. Bonvin, R. Berger, and E. Kalkhoven Impaired Peroxisome Proliferator-Activated Receptor {gamma} Function through Mutation of a Conserved Salt Bridge (R425C) in Familial Partial Lipodystrophy Mol. Endocrinol., May 1, 2007; 21(5): 1049 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. R. Velasco, M. Togashi, P. G. Walfish, R. P. Pessanha, F. N. Moura, G. B. Barra, P. Nguyen, R. Rebong, C. Yuan, L. A. Simeoni, et al. Thyroid Hormone Response Element Organization Dictates the Composition of Active Receptor J. Biol. Chem., April 27, 2007; 282(17): 12458 - 12466. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Santos, V. Afonso, G. B. Barra, M. Togashi, P. Webb, F. A. R. Neves, N. Lomri, and A. Lomri Negative Regulation of Superoxide Dismutase-1 Promoter by Thyroid Hormone Mol. Pharmacol., September 1, 2006; 70(3): 793 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Togashi, P. Nguyen, R. Fletterick, J. D. Baxter, and P. Webb Rearrangements in Thyroid Hormone Receptor Charge Clusters That Stabilize Bound 3,5',5-Triiodo-L-thyronine and Inhibit Homodimer Formation J. Biol. Chem., July 8, 2005; 280(27): 25665 - 25673. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sandler, P. Webb, J. W. Apriletti, B. R. Huber, M. Togashi, S. T. C. Lima, S. Juric, S. Nilsson, R. Wagner, R. J. Fletterick, et al. Thyroxine-Thyroid Hormone Receptor Interactions J. Biol. Chem., December 31, 2004; 279(53): 55801 - 55808. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Eeckhoute, B. Oxombre, P. Formstecher, P. Lefebvre, and B. Laine Critical role of charged residues in helix 7 of the ligand binding domain in Hepatocyte Nuclear Factor 4{alpha} dimerisation and transcriptional activity Nucleic Acids Res., November 15, 2003; 31(22): 6640 - 6650. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Sadow, E. Koo, O. Chassande, K. Gauthier, J. Samarut, J. Xu, B. W. O'Malley, H. Seo, Y. Murata, and R. E. Weiss Thyroid Hormone Receptor-Specific Interactions with Steroid Receptor Coactivator-1 in the Pituitary Mol. Endocrinol., May 1, 2003; 17(5): 882 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fischer, S. M. G. Dias, M. A. M. Santos, A. C. Alves, N. Zanchin, A. F. Craievich, J. W. Apriletti, J. D. Baxter, P. Webb, F. A. R. Neves, et al. Low Resolution Structures of the Retinoid X Receptor DNA-binding and Ligand-binding Domains Revealed by Synchrotron X-ray Solution Scattering J. Biol. Chem., April 25, 2003; 278(18): 16030 - 16038. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Marimuthu, W. Feng, T. Tagami, H. Nguyen, J. L. Jameson, R. J. Fletterick, J. D. Baxter, and B. L. West TR Surfaces and Conformations Required to Bind Nuclear Receptor Corepressor Mol. Endocrinol., February 1, 2002; 16(2): 271 - 286. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |